Skip to content

Pilates trial found less pain during breast cancer hormone therapy

Pain severity improved, while the overall anxiety difference reflected worsening in controls. Depressive symptoms did not improve significantly.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

In this small trial, pain severity decreased in the Pilates group. The overall anxiety result reflected an increase in anxiety among controls, rather than a reported overall reduction with Pilates. Analyses among aromatase inhibitor users found reductions in pain and anxiety with Pilates, but depressive symptoms did not significantly improve.

Keep in mind

This abstract-based account is limited by the small sample and missing results for pain interference, despite its inclusion among the outcomes. Subgroup findings do not establish that effects differ between hormone therapies.

THE RESULT, WITH CONTEXT

What researchers found

Reduced

Pain severity

Pilates versus control, baseline to 24 weeks: changes differed significantly between groups, with pain severity decreasing in the Pilates group. The abstract does not clearly define its reported change estimate.

Eur J Oncol Nurs, 2026 · Original source ↓

How change was assessed

Researchers assessed pain and emotional symptoms before and after the supervised program using standardized questionnaires. The reported group-by-time findings describe how outcomes changed differently between groups, rather than simply comparing scores at the end.

Reading the subgroup results

Results within aromatase inhibitor users help describe that subgroup, but the abstract does not report a direct test establishing a different response from tamoxifen users. Statistical significance within a subgroup is insufficient for that claim.

CHECK THE ORIGINAL

The original publication

The effects of 24 Weeks of mat pilates on pain, anxiety, and depressive symptoms in breast cancer survivors undergoing hormone therapy: A randomized controlled trial.

Bertoli J, Bertuol C, Ferreira Monteiro R et al.
Eur J Oncol Nurs · 2026

PubMed ID
41616490
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.